Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Abstract
The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell suicide programme that is essential for development, tissue homeostasis and immunity. Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischaemic conditions and drive neurodegeneration. We discuss the biochemical, structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold. These mechanistic insights into the functions of the BCL-2 family are illuminating the physiological control of apoptosis, the pathological consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Together with BOK, BCL2 family apoptosis regulator (BOK) [47], BAX and BAK are the only BCL2 family members characterized so far in mammalian cells for their ability to form pores across the outer mitochondrial membrane (OMM) and possibly other intracellular membranes [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“which is controlled by pro-apoptotic and anti-apoptotic members of the BCL2, apoptosis regulator (BCL2) protein family, a group of proteins sharing one to four BCL2 homology (BH) domains (i.e., BH1, BH2, BH3, and BH4) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Intrinsic apoptosis is a form of RCD initiated by a variety of microenvironmental perturbations including (but not limited to) growth factor withdrawal, DNA damage, endoplasmic reticulum (ER) stress, reactive oxygen species (ROS) overload, replication stress, microtubular alterations or mitotic defects [29–34].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“MOMP is antagonized by anti-apoptotic members of the BCL2 family, including BCL2 itself, BCL2 like 1 (BCL2L1; best known as BCL-XL), MCL1, BCL2 family apoptosis regulator (MCL1), BCL2 like 2 (BCL2L2; best known as BCL-W), and BCL2 related protein A1 (BCL2A1; best known—in human—as BFL-1) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Thus, most pro-survival BCL2 family members inhibit BAX and BAK by preventing their oligomerization and pore-forming activity either directly, upon physical sequestration at the OMM, or indirectly, following the sequestration of BH3-only activators [29, 64, 79, 110].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
Self-citationThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Self-citation
Cited by
Items 201–300 of 1,008
Demyelination as a rational therapeutic target for ischemic or traumatic brain injury
Shi, H., Hu, X., Leak, R. K., Shi, Y., An, C., Suenaga, J., Chen, J., & Gao, Y. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.017 · Cited by 151
“Indeed, both anti-apoptotic and proapoptotic factors such as the Bcl-2 family members and caspases are closely associated with mitochondria (Chandra et al., 2004; Czabotar et al., 2014).”
BackgroundWu, L., Mo, W., Feng, J., Li, J., Yu, Q., Li, S., Zhang, J., Chen, K., Ji, J., Dai, W., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15099 · Cited by 161
Targeting BCL-2-like Proteins to Kill Cancer Cells
Cory, S., Roberts, A. W., Colman, P. M., & Adams, J. M. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.07.001 · Cited by 161
Self-citationXia, H., Wang, W., Crespo, J., Kryczek, I., Li, W., Wei, S., Bian, Z., Maj, T., He, M., Liu, R. J., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan4631 · Cited by 150
“FIP200 controls Bak expression via maintaining microRNA1198-5p expression The cellular intrinsic apoptotic pathway is controlled by the balance of proapoptotic and antiapoptotic members of the Bcl-2 family (22).”
BackgroundTargeting BCL2 for the Treatment of Lymphoid Malignancies
Anderson, M. A., Huang, D., & Roberts, A. (2014) · Seminars in Hematology · doi:10.1053/j.seminhematol.2014.05.008 · Cited by 149
Recent advances in the development of Mcl-1 inhibitors for cancer therapy
Hird, A. W., & Tron, A. E. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.007 · Cited by 146
Cancer chemoresistance; biochemical and molecular aspects: a brief overview
Kachalaki, S., Ebrahimi, M., Khosroshahi, L. M., Mohammadinejad, S., & Baradaran, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.03.025 · Cited by 161
Mitochondrial function/dysfunction in white adipose tissue
Boudina, S., & Graham, T. E. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.081414 · Cited by 146
“…amino acid catabolism, ketogenesis and the urea cycle, formation of reactive oxygen species (ROS), calcium cycling and regulation of a variety of cell signalling pathways, including key roles as effectors of apoptosis and cell death (Starkov, 2008; Williams et al. 2013; Czabotar et al. 2014).”
BackgroundDoerflinger, M., Deng, Y., Whitney, P., Salvamoser, R., Engel, S., Kueh, A. J., Tai, L., Bachem, A., Gressier, E., Geoghegan, N. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.004 · Cited by 145
“Instead, Gsdmd–/–;Casp8–/–;Ripk3–/–;Bax–/–;Bak–/– iBMDMs still died upon Salmonella infection, containing cleaved caspases-3 and -7 (Figures 5A and 5B), indicating that the combined absence of BAX and BAK could be compensated for by rewiring the cell in a manner that allowed for caspase-1 to trigger the executioner ca…”
BackgroundInfluentialSelf-citationDeubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
Zhang, S., Zhang, M., Jing, Y., Yin, X., Ma, P., Zhang, Z., Wang, X., Di, W., & Zhuang, G. (2018) · Nature Communications · doi:10.1038/s41467-017-02693-9 · Cited by 144
Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player
Neagu, M. T., Constantin, C., Popescu, I., Zipeto, D., Tzanakakis, G. N., Nikitovic, D., Fenga, C., Stratakis, C. A., Spandidos, D. A., & Tsatsakis, A. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00348 · Cited by 169
“, fumarate, succinate, 2-hydroxyglutarate (2-HG), with pro-tumorigenic action (107)] and functional deficits in mitochondrial permeability transition (MPT) that induce the survival of tumor cells (108, 109).”
BackgroundCell death in chronic inflammation: breaking the cycle to treat rheumatic disease
Anderton, H., Wicks, I. P., & Silke, J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0455-8 · Cited by 162
Simpson, D. S., Pang, J., Weir, A. L., Kong, I. Y., Fritsch, M., Rashidi, M., Cooney, J. P., Davidson, K. C., Speir, M., Djajawi, T. M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.003 · Cited by 156
“Cytochrome c release from the inter-mitochondrial space into the cytosol is a hallmark of BAX/BAK-mediated apoptosis (Czabotar et al., 2014).”
BackgroundSelf-citationTargeting apoptotic pathways for cancer therapy
Tian, X., Srinivasan, P. R., Tajiknia, V., Uruchurtu, A. S. S., Seyhan, A. A., Carneiro, B. A., Cruz, A. D. L., Pinho-Schwermann, M. P., George, A., Zhao, S., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179570 · Cited by 172
“The main features of cells undergoing apoptosis include chromatin condensation, DNA fragmentation, membrane blebbing, and cytoskeletal rearrangement (4). caspase activation (19, 20); and (f) defects in extrinsic pathway signaling.”
The deadly landscape of pro‐apoptotic BCL‐2 proteins in the outer mitochondrial membrane
Luna‐Vargas, M. P. A., & Chipuk, J. E. (2016) · The FEBS Journal · doi:10.1111/febs.13624 · Cited by 142
Viruses and the Diversity of Cell Death
Danthi, P. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042435 · Cited by 142
Mali, R. S., Zhang, Q., DeFilippis, R., Cavazos, A., Kuruvilla, V. M., Raman, J., Mody, V., Choo, E. F., Dail, M., Shah, N. P., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.244020 · Cited by 150
Abbaszadeh, F., Fakhri, S., & Khan, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105069 · Cited by 141
The emergence of drug resistance to targeted cancer therapies: Clinical evidence
Sarmento‐Ribeiro, A. B., Scorilas, A., Gonçalves, A. C., Efferth, T., & Trougakos, I. P. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100646 · Cited by 149
BCL2‑regulated apoptotic process in myocardial ischemia‑reperfusion injury (Review)
Korshunova, A. Y., Blagonravov, M. L., NEBORAK, E. V., Syatkin, S. P., Sklifasovskaya, A. P., Semyatov, S. M., & Agostinelli, E. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4781 · Cited by 158
Wang, H., Dawber, R. S., Zhang, P., Walko, M., Wilson, A. J., & Wang, X. (2021) · Chemical Science · doi:10.1039/d1sc00165e · Cited by 153
Zhang, X., Tang, B., Luo, J., Yang, Y., Weng, Q., Fang, S., Zhao, Z., Tu, J., Chen, M., & Ji, J. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02130-8 · Cited by 172
Balancing Apoptosis and Autophagy for Parkinson’s Disease Therapy: Targeting BCL-2
Liu, J., Liu, W., & Yang, H. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00356 · Cited by 138
BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis
Huang, K., O’Neill, K. L., Li, J., Zhou, W., Han, N., Pang, X., Wu, W., Struble, L. R., Borgstahl, G., Liu, Z., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0231-y · Cited by 158
Endothelial cell apoptosis in angiogenesis and vessel regression
Watson, E. L., Grant, Z. L., & Coultas, L. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2577-y · Cited by 153
“Knockout mouse studies have revealed a diverse range of cell types and contexts in which individual pro-survival BCL2 family proteins promote cell survival [119].”
The Role of Osteocytes in Age-Related Bone Loss
Jilka, R. L., & O’Brien, C. A. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0297-0 · Cited by 145
Mitotic slippage: an old tale with a new twist
Sinha, D., Duijf, P. H. G., & Khanna, K. K. (2019) · Cell Cycle · doi:10.1080/15384101.2018.1559557 · Cited by 146
“[8] Czabotar PE, Lessene G, Strasser A, et al.”
BackgroundOrzalli, M. H., Prochera, A., Payne, L., Smith, A., Garlick, J. A., & Kagan, J. C. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.012 · Cited by 140
Optophysiology: Illuminating cell physiology with optogenetics
Tan, P., He, L., Huang, Y., & Zhou, Y. (2022) · Physiological Reviews · doi:10.1152/physrev.00021.2021 · Cited by 153
Bcl-2 family proteins: master regulators of cell survival
Hatok, J., & Račay, P. (2016) · BioMolecular Concepts · doi:10.1515/bmc-2016-0015 · Cited by 142
“Activation of BAX and/or BAK and consequent formation of the pore in OMM are followed by the release of cytochrome c and other pro-apoptotic proteins, including apoptosis inducing factor (AIF), Smac/DIABLO, EndoG and Omi/HtrA2, from intermembrane space of mitochondria to cytosol (2).”
BackgroundResultInfluentialCrashing the computer: apoptosis vs. necroptosis in neuroinflammation
Heckmann, B. L., Tummers, B., & Green, D. R. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0195-3 · Cited by 145
Anilkumar, U., Khacho, M., Cuillerier, A., Harris, R. A., Patten, D. A., Bilen, M., Iqbal, M. A., Guo, D. Y., Trudeau, L., Park, D. S., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2498-9 · Cited by 143
Niewiadomska, G., Niewiadomski, W., Steczkowska, M., & Gasiorowska, A. (2021) · Life · doi:10.3390/life11010028 · Cited by 131
“Mitochondrial impairment entails disturbance in, inter alia, ATP production, regulation of lipid and calcium metabolism, removal of reactive oxygen species (ROS), and induction of cell death [86,87].”
BackgroundBiological and neurological activities of astaxanthin (Review)
Si, P., & Zhu, C. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12816 · Cited by 156
“Bcl‐2 and Bcl‐xL inhibit the release of Cyt c and induce apop‐ tosis (48).”
BackgroundMatrix control of pancreatic cancer: New insights into fibronectin signaling
Topalovski, M., & Brekken, R. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.027 · Cited by 132
“Activation of this pathway results in upregulation of Bcl-2 through inhibition of Bad, ultimately blocking cytochrome c release from mitochondria, which results in reduced apoptosis [57, 58].”
BackgroundControl of mitochondrial physiology and cell death by the Bcl-2 family proteins Bax and Bok
D’Orsi, B., Mateyka, J., & Prehn, J. H. M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.010 · Cited by 144
“…and Bak form pores within the outer mitochondrial membrane that allow for the release of pro-apoptotic factors from the intermembrane space into the cytosol, a process called mitochondrial outer membrane permeabilization (MOMP) (Youle and Strasser, 2008; Chipuk et al., 2010; Czabotar et al., 2014).”
Transcriptomic responses to heat stress in rainbow trout Oncorhynchus mykiss head kidney
Huang, J., Li, Y., Liu, Z., Kang, Y., & Wang, J. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.08.002 · Cited by 129
“Repression of apoptosis may lead to cancer and autoimmune diseases, while high cell death rates may increase ischemic conditions and promote neurodegeneration [57].”
BackgroundThe Antisocial Network: Cross Talk Between Cell Death Programs in Host Defense
Snyder, A. G., & Oberst, A. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-112019-072301 · Cited by 131
“Immunol 17(4):262–75 [PubMed: 28287107]”
BackgroundInfluentialIAP Family of Cell Death and Signaling Regulators
Silke, J., & Vucic, D. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801430-1.00002-0 · Cited by 153
Nössing, C., & Ryan, K. M. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02020-0 · Cited by 150
“BAD in return is responsible for releasing this block [16].”
Redox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response
Zhang, L., Wang, K., Lei, Y., Li, Q., Nice, E. C., & Huang, C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.030 · Cited by 132
“domain death agonist), that induce the oligomerization of BAX (Bcl-2-associated X protein) and/or BAK (Bcl-2 antagonist or killer) [40].”
Rapamycin protects chondrocytes against IL-18-induced apoptosis and ameliorates rat osteoarthritis
Bao, J., Chen, Z., Xu, L., Wu, L., & Xiong, Y. (2020) · Aging · doi:10.18632/aging.102937 · Cited by 131
Murakami, T., Inagaki, N., & Kondoh, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.869414 · Cited by 152
Venetoclax: evidence to date and clinical potential
Salcedo, L. M. J., Desai, V., & Dalia, S. M. (2019) · Drugs in Context · doi:10.7573/dic.212574 · Cited by 144
Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery
Ashrafizadeh, M., Zarrabi, A., Mirzaei, S., Hashemi, F., Samarghandian, S., Zabolian, A., Hushmandi, K., Ang, H. L., Sethi, G., Kumar, A. P., et al. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112576 · Cited by 137
BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Alford, S. E., Kothari, A., Loeff, F. C., Eichhorn, J. M., Sakurikar, N., Goselink, H. M., Saylors, R. L., Jedema, I., Falkenburg, J. H. F., & Chambers, T. C. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1849 · Cited by 127
“It is well established that overexpression of prosurvival Bcl-2 proteins such as Bcl-2, Bcl-xL, or Mcl-1 blocks cell death induced by anticancer drugs, resulting in chemoresistance (5, 7).”
Biological determinants of radioresistance and their remediation in pancreatic cancer
Seshacharyulu, P., Baine, M. J., Souchek, J. J., Menning, M., Kaur, S., Yan, Y., Ouellette, M. M., Jain, M., Lin, C. H., & Batra, S. K. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.02.003 · Cited by 132
Barlaam, B. C., Casella, R., Cidado, J. R., Cook, C., Savi, C. D., Dishington, A. P., Donald, C. S., Drew, L., Ferguson, A. D., Ferguson, D., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01754 · Cited by 121
The role of interaction between autophagy and apoptosis in tumorigenesis (Review)
Xi, H., Wang, S., Wang, B., Hong, X., Liu, X., Li, M., Shen, R., & Dong, Q. (2022) · Oncology Reports · doi:10.3892/or.2022.8423 · Cited by 141
“It promotes apoptosis by inhibiting anti‐apoptotic Bcl‐2 protein and directly activating effector proteins to signal MOMP activation (57).”
BackgroundStaphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock
Krakauer, T. (2019) · Toxins · doi:10.3390/toxins11030178 · Cited by 131
“Activated caspase 8 can cleave proapoptotic molecule Bid to a truncated form, allowing for its interaction with two mitochondrial proapoptotic molecules, Bak and Bax [105].”
BackgroundVertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
Misale, S., Bozic, I., Tong, J., Peraza-Penton, A., Lallo, A., Baldi, F., Lin, K. H., Truini, M., Trusolino, L., Bertotti, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9305 · Cited by 122
In vivo CaspaseTracker biosensor system for detecting anastasis and non-apoptotic caspase activity
Tang, H. L., Tang, H. M., Fung, M. C., & Hardwick, J. M. (2015) · Scientific Reports · doi:10.1038/srep09015 · Cited by 125
Song, C.-Q., Li, Y., Mou, H., Moore, J., Park, A., Pomyen, Y., Hough, S., Kennedy, Z., Fischer, A., Yin, H., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.002 · Cited by 121
Westphal, D., Dewson, G., Menard, M., Frederick, P., Iyer, S., Bartolo, R., Gibson, L., Czabotar, P. E., Smith, B. J., Adams, J. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415142111 · Cited by 121
Self-citationCasara, P., Davidson, J., Claperon, A., Le Toumelin-Braizat, G., Vogler, M., Bruno, A., Chanrion, M., Lysiak-Auvity, G., Le Diguarher, T., Starck, J.-B., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24744 · Cited by 118
The TRAIL to cancer therapy: Hindrances and potential solutions
Wong, S. H. M., Kong, W. Y., Fang, C.-M., Loh, H., Chuah, L., Abdullah, S., & Ngai, S. C. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.08.008 · Cited by 123
Pannexin1 as mediator of inflammation and cell death
Yanguas, S. C., Willebrords, J., Johnstone, S. R., Maes, M., Decrock, E., Bock, M. D., Leybaert, L., Cogliati, B., & Vinken, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.10.006 · Cited by 130
“The former is mainly mediated by mitochondria along with the B-cell lymphoma-2 family of pro-apoptotic and anti-apoptotic proteins [115].”
BackgroundThe Bcl-2 Family in Host-Virus Interactions
Kvansakul, M., Caria, S., & Hinds, M. G. (2017) · Viruses · doi:10.3390/v9100290 · Cited by 127
“Considering the importance of Bcl-2 proteins in regulating apoptosis, as well as autophagy in higher organisms [11,84], it is unsurprising that numerous viruses have acquired sequence, functional and structural homologs of Bcl-2 to subvert host apoptosis as well as autophagy signalling for their own ends.”
BackgroundJoung, J., Kirchgatterer, P. C., Singh, A., Cho, J. H., Nety, S. P., Larson, R. C., Macrae, R. K., Deasy, R., Tseng, Y., Maus, M. V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29205-8 · Cited by 128
Hou, X., Tong, Q., Wang, W., Xiong, W., Shi, C., & Fang, J. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.03.007 · Cited by 115
McComb, S., Aguadé-Gorgorió, J., Harder, L., Marovca, B., Cario, G., Eckert, C., Schrappe, M., Stanulla, M., von Stackelberg, A., Bourquin, J.-P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad2986 · Cited by 115
Suhaili, S. H., Karimian, H., Stellato, M., Lee, T.-H., & Aguilar, M. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0308-0 · Cited by 132
“The apoptotic process is comprised of two main pathways, the death receptor pathway (extrinsic) and the mitochondrial mediated pathway (intrinsic) (Czabotar et al. 2014; Elmore 2007; Ichim and Tait 2016; Tait and Green 2010) and are summarized schematically in Fig.”
BackgroundInfluentialMacías-Rodríguez, R. U., Inzaugarat, M. E., Ruiz-Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051651 · Cited by 115
“This interaction takes place on the outer membrane of mitochondria and includes three different subgroups within the Bcl-2 family: BH3-only proteins (initiates apoptosis, includes Bid, Bim, and Puma), pro-survival elements (such as Bcl-2), and the effectors of apoptosis (Bax and Bak) [40].”
BackgroundTargeting regulated cell death in tumor nanomedicines
Zeng, Q., Ma, X., Song, Y., Chen, Q., Jiao, Q., & Zhou, L. (2021) · Theranostics · doi:10.7150/thno.67932 · Cited by 125
“To a certain extent, RCD can also be regulated by restraining the transduction of fatal signals and augmenting the ability of cells to respond adaptively to stress based on genetic manipulations or drugs [3, 4].”
BackgroundHe, W., Li, X., Morsch, M., Ismail, M., Liu, Y., Rehman, F. U., Zhang, D., Wang, Y., Zheng, M., Chung, R., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c00320 · Cited by 112
A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2
Renault, T. T., Dejean, L. M., & Manon, S. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.04.007 · Cited by 123
Manipulation of Neutrophils by Porphyromonas gingivalis in the Development of Periodontitis
Sochalska, M., & Potempa, J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00197 · Cited by 112
“Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 May 2017 | Volume 7 | Article 197 frequently engages BH3-only proteins, either transcriptionally or translationally, which allows them to either directly (Bim and tBid) or indirectly (all BH3-only) activate the pro-apoptotic effector proteins Bax…”
BackgroundLinalool prevents oxidative stress activated protein kinases in single UVB-exposed human skin cells
Gunaseelan, S., Balupillai, A., Govindasamy, K., Ramasamy, K., Muthusamy, G., Shanmugam, M., Radhiga, T., Robert, B. M., Prasad, N. R., Ponniresan, V. K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176699 · Cited by 122
Wu, D., Chen, X., Sun, K., Wang, L., Chen, S., & Zhao, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0709-5 · Cited by 112
“BCL-xL, a member of the BCL-2 family, exhibits anti-apoptotic effects and has also been found to be upregulated in bladder cancer [14, 15].”
BackgroundEndoplasmic Reticulum Stress Signaling and Neuronal Cell Death
Merighi, A., & Lossi, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315186 · Cited by 130
Nonsense‐mediated mRNA decay: The challenge of telling right from wrong in a complex transcriptome
Kishor, A., Fritz, S. E., & Hogg, J. R. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1548 · Cited by 123
“These findings suggest that the protective mechanism causes a critical failure to eliminate aberrant BCL2:IGH fusion transcripts in B cell lymphomas and may also contribute to the survival of the many cancers that rely on BCL2 overexpression (Czabotar et al., 2014).”
BackgroundFang, J., Zhao, X., Li, S., Xing, X., Wang, H., Lazarovici, P., & Zheng, W. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1419-2 · Cited by 117
Progress in targeting the BCL-2 family of proteins
Garner, T. P., Lopez, A., Reyna, D. E., Spitz, A. Z., & Gavathiotis, E. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.06.014 · Cited by 110
Comparing the effects of different cell death programs in tumor progression and immunotherapy
Messmer, M. N., Snyder, A. G., & Oberst, A. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0214-4 · Cited by 110
Xiao, B., Viennois, É., Chen, Q., Wang, L., Han, M. K., Zhang, Y., Zhang, Z., Kang, Y., Wan, Y., & Merlin, D. (2018) · ACS Nano · doi:10.1021/acsnano.7b08499 · Cited by 115
Li, M. (2021) · APOPTOSIS · doi:10.1007/s10495-021-01667-z · Cited by 127
Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
Ghosh, J. C., Siegelin, M. D., Vaira, V., Faversani, A., Tavecchio, M., Chae, Y. C., Lisanti, S., Rampini, P., Giroda, M., Caino, M. C., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju502 · Cited by 108
“The idea of targeting mitochondrial integrity for cancer therapy (19) has recently gained attention (35), and regulators of Bcl-2 proteins (36), oxidative phosphorylation (37), and redox mechanisms (38) have progressed through (pre)clinical development.”
BackgroundEpstein-Barr virus-encoded microRNAs as regulators in host immune responses
Wang, M., Yu, F., Wu, W., Wang, Y., Ding, H., & Qian, L. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24562 · Cited by 123
“The BH3-interacting domain death agonist (BID) serves as a caspase substrate that engages the mitochondrial pathway to amplify the apoptotic response [96].”
BackgroundZhang, Q.-L., Yang, J.-J., & Zhang, H.-S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.037 · Cited by 110
Denoyelle, C., Lambert, B., Meryet‐Figuière, M., Vigneron, N., Brotin, É., Lecerf, C., Abeilard, E., Giffard, F., Louis, M.-H., Gauduchon, P., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.389 · Cited by 114
“The BCL-2 family members constitute essential intracellular players in the apoptotic machinery.(4) This family is composed of pro- and anti-apoptotic proteins sharing at least one of four BCL-2 homology domains (BH1 to 4).”
InfluentialZhu, J., Yu, W., Liu, B., Wang, Y., Shao, J., Wang, J., Xia, K., Liang, C., Fang, W., Zhou, C., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.488 · Cited by 108
“be involved in the mitochondrial-mediated apoptosis pathway, which activates the caspase cascade.(36) Thus, we investigated Bax, Bcl-XL and Bcl-2 key members of the Bcl-2 family.”
BackgroundMyeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer
Goodwin, C. M., Rossanese, O. W., Olejniczak, E. T., & Fesik, S. W. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.73 · Cited by 118
“Many cancer types aberrantly block oncogenic apoptotic signaling by increasing steady-state expression of one or more of these proteins through genetic amplification, transcript upregulation or reduced degradation.(8) It is therefore unsurprising that Bcl-2 family inhibitors, such as ABT-263 and ABT-199, have displaye…”
BackgroundThe Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
Cui, D., Qu, R., Liu, D., Xiong, X., Liang, T., & Zhao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.775507 · Cited by 118
“Mechanistically, upon apoptotic induction, p53 translocates from the nucleus to the mitochondrial outer membrane, and interacts with pro-survival Bcl-2 family members (such as Bcl-w and BclXL) to release pro-apoptotic Bcl-2 proteins (such as Bax and Bak) to induce apoptosis (Vaseva and Moll, 2009; Czabotar et al., 201…”
BackgroundMitochondrial regulation of cell death: a phylogenetically conserved control
Galluzzi, L., Kepp, O., & Kroemer, G. (2016) · Microbial Cell · doi:10.15698/mic2016.03.483 · Cited by 105
Banerjee, K., & Mandal, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.04.009 · Cited by 109
“5e–g] which has been previously attributed to be the underlying cause of the disruption of the mitochondrial outer membrane [18].”
Zhou, J., Ahmad, F., Parikh, S., Hoffman, N. E., Rajan, S., Verma, V. K., Song, J., Yuan, A., Shanmughapriya, S., Guo, Y., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308544 · Cited by 103
Mechanisms of microcystin-LR-induced cytoskeletal disruption in animal cells
Zhou, M., Tu, W.-W., & Xu, J. (2015) · Toxicon · doi:10.1016/j.toxicon.2015.05.005 · Cited by 113
“Unlike Bax, Bcl-2 is an antiapoptotic member of this family that is mainly localized to the mitochondrial membrane and forms heterodimers with Bax to prevent mitochondrial changes during apoptosis (Aggarwal et al., 1990; Czabotar et al., 2014; Hockenbery et al., 1990).”
Bortolotto, L. F. B., Barbosa, F. R., SILVA, G. H. D. O., Bitencourt, T. A., Beleboni, R. O., Baek, S. J., Marins, M., & Fachin, A. L. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.047 · Cited by 105
Chemopreventive effects of some popular phytochemicals on human colon cancer: a review
Zhao, Y., Hu, X., Zuo, X., & Wang, M. (2018) · Food & Function · doi:10.1039/c8fo00850g · Cited by 109
Pei, J., Fu, B., Jiang, L., & Sun, T. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s188235 · Cited by 114
Cellular senescence and radiation-induced pulmonary fibrosis
He, Y., Thummuri, D., Zheng, G., Okunieff, P., Citrin, D. E., Vujaskovic, Z., & Zhou, D. (2019) · Translational Research · doi:10.1016/j.trsl.2019.03.006 · Cited by 103
From Inhibition to Degradation: Targeting the Antiapoptotic Protein Myeloid Cell Leukemia 1 (MCL1)
Papatzimas, J. W., Gorobets, E., Maity, R., Muniyat, M. I., MacCallum, J. L., Neri, P., Bahlis, N. J., & Derksen, D. J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00455 · Cited by 103
Kikuchi, H., Yuan, B., Hu, X., & Okazaki, M. (2019) · PubMed · Cited by 109
Update on the adverse effects of microcystins on the liver
Shi, L., Du, X., Liu, H., Chen, X., Ya, M., Wang, R., Tian, Z., Zhang, S., Guo, H., & Zhang, H. (2021) · Environmental Research · doi:10.1016/j.envres.2021.110890 · Cited by 110
Anti-apoptotic BCL-2 family proteins in acute neural injury
Anilkumar, U., & Prehn, J. H. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00281 · Cited by 115
“…properties: (a) anti-apoptotic BCL-2 proteins including BCL2 itself, BCL-XL (BCL-extra long), MCL-1 and BCL-W which contain four BH(1-4) domains (Czabotar et al., 2014); (b) pro pro-apoptotic proteins BAX (BCL-2-associated × protein), BAK (BCL-2-antagonist/killer-1) (Wei et al., 2001) and…”
The NOXA–MCL1–BIM axis defines lifespan on extended mitotic arrest
Haschka, M. D., Soratroi, C., Kirschnek, S., Häcker, G. A., Hilbe, R., Geley, S., Villunger, A., & Fava, L. L. (2015) · Nature Communications · doi:10.1038/ncomms7891 · Cited by 113
Cummins, N. W., Sainski, A. M., Dai, H., Natesampillai, S., Pang, Y., Bren, G. D., Correia, M. C. M. D. A., Sampath, R., Rizza, S. A., O’Brien, D. R., et al. (2016) · Journal of Virology · doi:10.1128/jvi.03179-15 · Cited by 104
Red ginseng and cancer treatment.
Wang, C.-Z., Anderson, S. L. C., Du, W., He, T., & Yuan, C.-S. (2016) · PubMed · doi:10.3724/sp.j.1009.2016.00007 · Cited by 114
Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication
He, M., Zhou, Z., Wu, G. Y., Chen, Q., & Wan, Y. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.001 · Cited by 107
Liu, Y., Wen, P., Zhang, X., Dai, Y., & He, Q. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3651 · Cited by 112
Metadata
- Authors
- Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Strasser, Andreas
- Adams, Jerry M.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2013-12-20
- Volume
- 15
- Issue
- 1
- Pages
- 49-63
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2088883749
- Cited by
- 3,219
- References
- 218
- Citations by year
- 2026: 164 · 2025: 220 · 2024: 249 · 2023: 230 · 2022: 265 · 2021: 319 · 2020: 299 · 2019: 285 · 2018: 314 · 2017: 292 · 2016: 287 · 2015: 209 · 2014: 77 · 2013: 1
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2 family proteins, apoptosis, mitochondrial outer membrane, BCL-2 inhibitor, cancer therapy, autoimmune disease, neurodegeneration, ischemia, apoptosis regulation
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Models, Molecular, Molecular Sequence Data, Neoplasms, Signal Transduction, Apoptosis, Protein Structure, Secondary, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Protein Multimerization, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.